drugset / Trial / NCT01587885

Comparison of Two Omeprazole-Containing Products for Relief of Frequent Heartburn (MK-0764A-036)

NCT01587885 ↗

Phase 4 Completed 48 enrolled Bayer
RandomizedCrossoverOpen-labelTreatment

Summary

This study will evaluate a single ingredient product (omeprazole 20 mg) with a combination product capsule (omeprazole 20 mg + sodium bicarbonate 1100 mg) in participants with frequent heartburn.

Timeline

Start
2012-01
Primary completion
2012-04
Completion
2012-05

Outcome

Met primary endpoint

registry Omeprazole 20 mg + Sodium Bicarbonate 1100 mg vs Omeprazole 20 mg; p <0.0480; Hazard Ratio (HR) 1.548; Regression, Cox NCT01587885 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Omeprazole Other / unclassified 20 mg Oral
Subject sodium bicarbonate Diagnostic / imaging agent 1100 mg Oral

Indications